Работы, на которые ссылается эта работа

Работ: 30

Работа: Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
Armand Van Deun, Aung Kya Jai Maug, Md Abdul Hamid Salim +4
Статья2010Цитирований: 11
ABI
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
Andrew Nunn, Patrick Phillips, Sarah Meredith +16
Статья2019Цитирований: 6
ABI
High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses
Alberto Piubello, Souleymane Hassane Harouna, Mahamadou Bassirou Souleymane +5
Статья2014Цитирований: 6
ABI
Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries
Arnaud Trébucq, V Schwoebel, Zacharie Kashongwe +15
Статья2017Цитирований: 6
ABI
High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon
Christopher Kuaban, J Noeske, Hans L. Rieder +3
Статья2015Цитирований: 5
ABI
Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan
Shona Horter, Beverley Stringer, Jane Greig +5
СтатьяTuberculosis Research and EpidemiologyBMC Infectious Diseases2016Цитирований: 4
ABI
Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses
Faiz Ahmad Khan, M Salim, Philipp du Cros +9
Обзорная статьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2017Цитирований: 4
ABI
An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis
Mayara Lisboa Bastos, Zhiyi Lan, Dick Menzies
Обзорная статья2017Цитирований: 4
ABI
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Nafees Ahmad, Shama D. Ahuja, Onno W. Akkerman +97
Обзорная статья2018Цитирований: 4
ABI
Risk Factors Associated with Default from Multi- and Extensively Drug-Resistant Tuberculosis Treatment, Uzbekistan: A Retrospective Cohort Analysis
Maeve K. Lalor, Jane Greig, Sholpan Allamuratova +6
Статья2013Цитирований: 4
ABI
Prediction of Creatinine Clearance from Serum Creatinine
Donald W. Cockcroft, Henry Gault
Статья2008Цитирований: 3
ABI
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance
J. Peter Cegielski, Ekaterina V. Kurbatova, Martie van der Walt +74
Статья2015Цитирований: 3
ABI
WHO recommendations on shorter treatment of multidrug-resistant tuberculosis
Giovanni Sotgiu, Simon Tiberi, Lia D’Ambrosio +3
Статья2016Цитирований: 2
ABI
Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations
Francis Varaine, Lorenzo Guglielmetti, Helena Huerga +5
Другое2016Цитирований: 2
ABI
Preferential adherence to antiretroviral therapy over tuberculosis treatment: A qualitative study of drug-resistant TB/HIV co-infected patients in South Africa
Amrita Daftary, Nesri Padayatchi, Max R. O’Donnell
Статья2014Цитирований: 2
ABI
Research Protocol - Effectiveness of a simplified short regimen for Multidrug Resistant Tuberculosis treatment in Karakalpakstan, Uzbekistan
Philipp du Cros, Khamraev Atadjan, Mirzagalib Tillashaikhov +19
Статья2014Цитирований: 2
ABI
Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe
Christoph Lange, Raquel Duarte, M. Jachym +7
Другое2016Цитирований: 2
ABI
World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
Dennis Falzon, Holger J. Schünemann, Elizabeth Harausz +4
Статья2017Цитирований: 2
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI